Planet Labs PBC (PL) concluded trading on Thursday at a closing price of $3.97, with 3.61 million shares of worth about $14.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 119.34% during that period and on Thursday the price saw a loss of about -1.73%. Currently the company’s common shares owned by public are about 275.27M shares, out of which, 198.30M shares are available for trading.
Stock saw a price change of -4.11% in past 5 days and over the past one month there was a price change of -11.97%. Year-to-date (YTD), PL shares are showing a performance of -1.73% which increased to 66.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.67 but also hit the highest price of $4.99 during that period. The average intraday trading volume for Planet Labs PBC shares is 3.91 million. The stock is currently trading -2.91% below its 20-day simple moving average (SMA20), while that difference is up 17.40% for SMA50 and it goes to 63.60% higher than SMA200.
Planet Labs PBC (NYSE: PL) currently have 275.27M outstanding shares and institutions hold larger chunk of about 28.67% of that.
The stock has a current market capitalization of $1.18B and its 3Y-monthly beta is at 1.32. It has posted earnings per share of -$0.41 in the same period. It has Quick Ratio of 2.32 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PL, volatility over the week remained 7.94% while standing at 9.50% over the month.
Analysts are in expectations that Planet Labs PBC (PL) stock would likely to be making an EPS of -0.02 in the current quarter, while forecast for next quarter EPS is -0.02 and it is -0.07 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.04 which is -0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.06 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 34.21% while it is estimated to increase by 53.39% in next year. EPS is likely to shrink at an annualized rate of 25.00% for next 5-years, compared to annual growth of 35.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on September 06, 2024 offering a Buy rating for the stock and assigned a target price range of between $7 and $5 to it. On May 02, 2023, JMP Securities Initiated their recommendations, while on April 18, 2023, Citigroup Initiated their ratings for the stock with a price target of $6. Stock get an Equal-weight rating from Morgan Stanley on January 23, 2023.
